Calcium oxalate (CaOx) uroliths cannot be dissolved medically and require physical removal, followed by lifelong prevention strategies to reduce the high recurrence risk. CaOx accounts for 41%–49% of all canine urolith submissions, and up to 50% of affected dogs experience recurrence within 2–3 years.Journal of Vete…+1
Physical removal is the first priority for clinically significant CaOx urocystoliths. The current consensus guideline prioritizes minimally invasive retrieval — voiding urohydropulsion, cystoscopic basket retrieval, or intracorporeal laser lithotripsy — over open cystotomy.Journal of Vete…+2 Open cystotomy carries an incomplete removal risk of up to 20%, often due to poor visualization or hemorrhage.Journal of the… When open cystotomy is performed, intraoperative urethrocystoscopy reduces operating time and improves urolith detection in male dogs over 7 kg.Journal of the… Postoperative imaging is essential to confirm complete removal; incomplete removal may necessitate immediate revision surgery.Journal of the…
For upper urinary tract CaOx uroliths, minimally invasive approaches are preferred to protect renal function. Extracorporeal shockwave lithotripsy (ESWL) is feasible for nephroliths ≤1.5 cm in diameter; endoscopic nephrolithotomy is recommended for nephroliths >1–1.5 cm or when ESWL is not suitable.Journal of the… Obstructive ureterolithiasis requires immediate intervention; ureteral stenting is the recommended minimally invasive approach in dogs.Journal of the… Non-obstructive nephroliths that are not causing recurrent infection, pain, or progressive renal parenchymal compression do not require removal.Journal of the…
Prevention centers on reducing urine calcium oxalate relative supersaturation through dietary modification and increased water intake. Regardless of stone type, increasing water intake is the single most universally applicable intervention.Veterinary Clin… The urine specific gravity target is ≤1.020 in dogs.AAHA Clinical G… Dietary management for CaOx includes low-oxalate ingredients, controlled calcium with an appropriate calcium-to-phosphorus ratio, and avoidance of vitamin C supplementation.AAHA Clinical G… Dietary precursor restriction and urine pH manipulation are subject to ongoing controversy for CaOx, in contrast to struvite, urate, xanthine, and cystine uroliths where these interventions are more clearly effective.Veterinary Clin…
Idiopathic hypercalciuria is the primary metabolic risk factor to identify and address. Most dogs with CaOx urolithiasis have hypercalciuria with normal serum calcium concentration.Journal of Vete… Hydrochlorothiazide reduces urinary calcium excretion by approximately 40% in CaOx stone-forming dogs and is the targeted pharmacologic intervention for confirmed hypercalciuria.Journal of Vete… Urine calcium-to-creatinine ratio (UCaCr) is significantly higher in dogs with CaOx urolithiasis compared to stone-free controls, though substantial overlap between groups exists.Journal of Vete… Fractional excretion of calcium is an alternative metric under investigation but lacks established reference data in dogs.Journal of Vete…
Serum lipid screening is recommended as part of metabolic staging in CaOx urolith dogs. Hypertriglyceridemia is associated with increased odds of CaOx lower urinary tract uroliths in dogs, with odds increasing by a factor of 4.34 per mmol/L of serum triglycerides in multivariable analysis.Journal of Vete… Body condition score is also independently associated with urolith presence, with odds increasing by a factor of 2.43 per unit on the 1–9 BCS scale in univariate analysis.Journal of Vete…
Breed-based screening in high-risk dogs should begin at 5–6 years of age, which is 2–3 years before the mean age of first CaOx urolith presentation (8.4 ± 2.8 years).Journal of Vete… All 12 high-risk breeds identified in epidemiologic evaluation are small-breed dogs; all 14 low-risk breeds are medium to large breeds.Journal of Vete… Male dogs are at higher risk than females.Journal of Vete…
Would you like to go deeper on the hydrochlorothiazide dosing protocol and monitoring approach for dogs with confirmed hypercalciuric CaOx urolithiasis?